Skip to main content
OpenTrials

Clinical trial condition

HIV Infections

Explore clinical trials studying HIV Infections. Study availability and eligibility vary by location and protocol.

3,320 public trials 107 recruiting studies
Refine in advanced search Browse all conditions

HIV Infections trial results

Completed

A Phase IV Study to Assess the Impact of the Change of Antiretroviral Treatment From Dual Therapy to Triple Therapy on Inflammation in Patients With HIV Infection

NCT04076423

Conditions
Blood-Borne Infections, Communicable Diseases, Genital Diseases, +11 more
Locations
  • Hospital San Pedro Logroño, La Rioja, Spain
  • Hospital Universitario Príncipe de Asturias Alcalá de Henares, Madrid, Spain
  • Hospital Universitario Puerta de Hierro Majadahonda, Madrid, Spain
  • Hospital de Bellvitge Barcelona, Spain
View all 18 locations
View Trial Details
Completed

Study of Semaglutide for Non-Alcoholic Fatty Liver Disease (NAFLD), a Metabolic Syndrome With Insulin Resistance, Increased Hepatic Lipids, and Increased Cardiovascular Disease Risk (The SLIM LIVER Study)

NCT04216589

Conditions
Blood-Borne Infections, Communicable Diseases, Digestive System Diseases, +16 more
Locations
  • Alabama CRS (Site ID: 31788) Birmingham, Alabama, United States
  • University of Colorado Hospital CRS (Site ID: 6101) Aurora, Colorado, United States
  • Johns Hopkins University CRS Baltimore, Maryland, United States
  • Massachusetts General Hospital CRS (MGH CRS) (Site ID: 101) Boston, Massachusetts, United States
View Trial Details
Completed

Regimen Switch to Dolutegravir + Rilpivirine From Current Antiretroviral Regimen in Human Immunodeficiency Virus Type 1 Infected and Virologically Suppressed Adults (SWORD-1)

NCT02429791

Conditions
Blood-Borne Infections, Communicable Diseases, Genital Diseases, +11 more
Locations
  • GSK Investigational Site Long Beach, California, United States
  • GSK Investigational Site Los Angeles, California, United States
  • GSK Investigational Site Los Angeles, California, United States
  • GSK Investigational Site San Francisco, California, United States
View all 65 locations
View Trial Details

Related conditions